Novo Nordisk A/S (CPH: NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
589.20
-154.00 (-20.72%)
Dec 20, 2024, 4:59 PM CET

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of DKK 2.61 trillion. The enterprise value is 2.59 trillion.

Market Cap 2.61T
Enterprise Value 2.59T

Important Dates

The next estimated earnings date is Wednesday, February 5, 2025.

Earnings Date Feb 5, 2025
Ex-Dividend Date Aug 15, 2024

Share Statistics

Novo Nordisk has 4.42 billion shares outstanding. The number of shares has decreased by -0.86% in one year.

Current Share Class n/a
Shares Outstanding 4.42B
Shares Change (YoY) -0.86%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 33.78%
Float 3.16B

Valuation Ratios

The trailing PE ratio is 27.79 and the forward PE ratio is 22.42. Novo Nordisk's PEG ratio is 1.11.

PE Ratio 27.79
Forward PE 22.42
PS Ratio 9.71
PB Ratio 21.77
P/TBV Ratio 39.48
P/FCF Ratio 33.53
P/OCF Ratio n/a
PEG Ratio 1.11
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.26, with an EV/FCF ratio of 33.30.

EV / Earnings 27.33
EV / Sales 9.57
EV / EBITDA 19.26
EV / EBIT 20.62
EV / FCF 33.30

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.47.

Current Ratio 0.94
Quick Ratio 0.74
Debt / Equity 0.47
Debt / EBITDA 0.42
Debt / FCF 0.73
Interest Coverage 825.54

Financial Efficiency

Return on equity (ROE) is 88.73% and return on invested capital (ROIC) is 52.81%.

Return on Equity (ROE) 88.73%
Return on Assets (ROA) 22.49%
Return on Capital (ROIC) 52.81%
Revenue Per Employee 3.76M
Profits Per Employee 1.32M
Employee Count 64,319
Asset Turnover 0.78
Inventory Turnover 1.23

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.65% in the last 52 weeks. The beta is 0.15, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y) 0.15
52-Week Price Change -13.65%
50-Day Moving Average 763.36
200-Day Moving Average 869.33
Relative Strength Index (RSI) 21.95
Average Volume (20 Days) 4,215,413

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of DKK 270.58 billion and earned 94.72 billion in profits. Earnings per share was 21.20.

Revenue 270.58B
Gross Profit 229.07B
Operating Income 125.48B
Pretax Income 119.25B
Net Income 94.72B
EBITDA 133.10B
EBIT 125.48B
Earnings Per Share (EPS) 21.20
Full Income Statement

Balance Sheet

The company has 74.88 billion in cash and 56.97 billion in debt, giving a net cash position of 17.91 billion or 4.05 per share.

Cash & Cash Equivalents 74.88B
Total Debt 56.97B
Net Cash 17.91B
Net Cash Per Share 4.05
Equity (Book Value) 120.52B
Book Value Per Share 27.07
Working Capital -13.20B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 118.22 billion and capital expenditures -40.47 billion, giving a free cash flow of 77.75 billion.

Operating Cash Flow 118.22B
Capital Expenditures -40.47B
Free Cash Flow 77.75B
FCF Per Share 17.57
Full Cash Flow Statement

Margins

Gross margin is 84.66%, with operating and profit margins of 46.37% and 35.01%.

Gross Margin 84.66%
Operating Margin 46.37%
Pretax Margin 44.07%
Profit Margin 35.01%
EBITDA Margin 49.19%
EBIT Margin 46.37%
FCF Margin 28.73%

Dividends & Yields

This stock pays an annual dividend of 9.90, which amounts to a dividend yield of 1.68%.

Dividend Per Share 9.90
Dividend Yield 1.68%
Dividend Growth (YoY) 39.93%
Years of Dividend Growth 6
Payout Ratio 46.60%
Buyback Yield 0.86%
Shareholder Yield 2.54%
Earnings Yield 3.60%
FCF Yield 2.98%
Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date Sep 13, 2023
Split Type Forward
Split Ratio 2

Scores

Novo Nordisk has an Altman Z-Score of 10.12.

Altman Z-Score 10.12
Piotroski F-Score n/a